ZA989786B - Method of reducing craving in mammals - Google Patents

Method of reducing craving in mammals

Info

Publication number
ZA989786B
ZA989786B ZA989786A ZA989786A ZA989786B ZA 989786 B ZA989786 B ZA 989786B ZA 989786 A ZA989786 A ZA 989786A ZA 989786 A ZA989786 A ZA 989786A ZA 989786 B ZA989786 B ZA 989786B
Authority
ZA
South Africa
Prior art keywords
mammals
reducing craving
craving
reducing
Prior art date
Application number
ZA989786A
Inventor
Vicki Coffin
Paul W Glue
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA989786B publication Critical patent/ZA989786B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA989786A 1997-10-28 1998-10-27 Method of reducing craving in mammals ZA989786B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95921397A 1997-10-28 1997-10-28

Publications (1)

Publication Number Publication Date
ZA989786B true ZA989786B (en) 1999-04-28

Family

ID=25501785

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989786A ZA989786B (en) 1997-10-28 1998-10-27 Method of reducing craving in mammals

Country Status (16)

Country Link
EP (1) EP1043980A2 (en)
JP (1) JP2001520989A (en)
KR (1) KR20010031470A (en)
CN (1) CN1283116A (en)
AR (1) AR015984A1 (en)
AU (1) AU1110099A (en)
BR (1) BR9814830A (en)
CA (1) CA2308453A1 (en)
CO (1) CO4970824A1 (en)
HU (1) HUP0100115A2 (en)
IL (1) IL135659A0 (en)
NO (1) NO20002149L (en)
PE (1) PE122299A1 (en)
SK (1) SK5812000A3 (en)
WO (1) WO1999021540A2 (en)
ZA (1) ZA989786B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
ATE427745T1 (en) 2001-11-05 2009-04-15 Krele Pharmaceuticals Llc COMPOSITIONS AND METHODS FOR INCREASE COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND FOR TREATING ALCOHOLSM
DK2611440T3 (en) 2010-09-01 2017-05-15 Tonix Pharmaceuticals Inc Treatment for cocaine addiction
HUE058696T2 (en) 2012-07-12 2022-09-28 Emalex Biosciences Inc Fused benzazepines for treatment of tourette's syndrome
HUE049848T2 (en) 2013-10-18 2020-11-30 Emalex Biosciences Inc Fused benzazepines for treatment of stuttering
CN110327350B (en) * 2019-07-11 2021-02-23 温州医科大学 Application of dopamine D1 receptor antagonist SCH39166 in preparation of drugs for treating pathological angiogenesis of eyes
CN110833621A (en) * 2019-12-06 2020-02-25 中国医科大学 Application of dopamine receptor 1 antagonist in preparation of drug for treating mouse schizophrenia caused by ketamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
WO1997046239A1 (en) * 1996-06-06 1997-12-11 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists

Also Published As

Publication number Publication date
NO20002149L (en) 2000-06-26
CO4970824A1 (en) 2000-11-07
PE122299A1 (en) 1999-12-04
NO20002149D0 (en) 2000-04-27
CA2308453A1 (en) 1999-05-06
KR20010031470A (en) 2001-04-16
CN1283116A (en) 2001-02-07
BR9814830A (en) 2000-10-03
SK5812000A3 (en) 2000-12-11
WO1999021540A3 (en) 1999-09-02
WO1999021540B1 (en) 1999-10-28
AU1110099A (en) 1999-05-17
JP2001520989A (en) 2001-11-06
EP1043980A2 (en) 2000-10-18
WO1999021540A2 (en) 1999-05-06
IL135659A0 (en) 2001-05-20
HUP0100115A2 (en) 2001-06-28
AR015984A1 (en) 2001-05-30

Similar Documents

Publication Publication Date Title
IL127912A0 (en) Method of activating dendritic cells
GB2311695B (en) Method of and telephone with call-reminding and auto-dialing
EP0767524A3 (en) Method for balancing power sources and structure
PL332741A1 (en) Battery and method of making same
EP0720228A3 (en) Semiconductor connection structure and method
ZA989399B (en) Method and composition
GB2298713B (en) Method and composition
EP0716478A3 (en) Electrical connection structure and method
IL135659A0 (en) Method of reducing craving in mammals
ZA989398B (en) Method and composition (l)
PL326102A1 (en) Decorative laminate and method of making same
EP0707343A3 (en) Structure and method for connecting to integrated circuitry
GB2323745B (en) System and method relating to telecommunications
GB2332181B (en) Method of synchronizing first and second steering arrangements
GB9626906D0 (en) Method of blow-moulding
PL339770A1 (en) Stator and method of making same
GB9621533D0 (en) Composition and method
PL334918A1 (en) Stator and method of making same
GB2311218B (en) Improvements in and relating to baths
GB9726186D0 (en) Method of moulding
IL117256A0 (en) Method of manufacturing an intermediate of kvass
GB9626046D0 (en) Methods of manufacturing engines
PL322291A1 (en) Structural component and method of making same
PL320015A1 (en) Method of obtaining 4-chloro-2-methylphenylacetic acid in solid form
TW297376U (en) Structure of scooter